Expand IMVT Menu
IMVT MENU

IMVT Latest Press Releases

-- January 23, 2026 --

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 Globe Newswire 5:25 PM

-- January 5, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) PRNewswire 12:00 PM

-- December 11, 2025 --

Immunovant Announces Pricing of $550 Million Common Stock Financing Globe Newswire 1:29 AM

-- November 10, 2025 --

Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025 Globe Newswire 7:00 AM

-- October 27, 2025 --

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025 Globe Newswire 4:10 PM

-- September 17, 2025 --

IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc. - IMVT Globe Newswire 5:29 PM

-- September 12, 2025 --

IMMUNOVANT INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc. - IMVT Business Wire 4:22 PM

-- September 3, 2025 --

Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients Globe Newswire 1:01 PM
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients Globe Newswire 12:57 PM
Market Data Delayed 15 Minutes